.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Covington
Cipla
US Department of Justice
AstraZeneca
McKesson
McKinsey
Johnson and Johnson
Cerilliant
Chubb
UBS

Generated: September 24, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 018615

« Back to Dashboard
NDA 018615 describes SULFATRIM PEDIATRIC, which is a drug marketed by Sti Pharma Llc and is included in one NDA. It is available from three suppliers. Additional details are available on the SULFATRIM PEDIATRIC profile page.

The generic ingredient in SULFATRIM PEDIATRIC is sulfamethoxazole; trimethoprim. There are twenty-six drug master file entries for this compound. Sixty-five suppliers are listed for this compound. Additional details are available on the sulfamethoxazole; trimethoprim profile page.

Summary for NDA: 018615

Tradename:
2
Applicant:
1
Ingredient:
1
Patents:0
Therapeutic Class:Antibacterials
Formulation / Manufacturing:see details

Suppliers and Packaging for NDA: 018615

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
SULFATRIM
sulfamethoxazole; trimethoprim
SUSPENSION;ORAL 018615 NDA Atlantic Biologicals Corps 17856-0007 17856-0007-1 72 CUP in 1 BOX (17856-0007-1) > 10 mL in 1 CUP
SULFATRIM
sulfamethoxazole; trimethoprim
SUSPENSION;ORAL 018615 NDA Atlantic Biologicals Corps 17856-0007 17856-0007-2 20 mL in 1 CUP (17856-0007-2)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:SUSPENSION;ORALStrength200MG/5ML;40MG/5ML
Approval Date:Jan 7, 1983TE:ABRLD:No

Summary for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:SUSPENSION;ORALStrength200MG/5ML;40MG/5ML
Approval Date:Jan 7, 1983TE:RLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Daiichi Sankyo
Boehringer Ingelheim
Argus Health
Mallinckrodt
Teva
Healthtrust
Covington
Cerilliant
Baxter
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot